EFFICACY OF SUBCUTANEOUS ROPIVACAINE WOUND INFILTRATION FOR POSTOPERATIVE ANALGESIA AFTER CAESAREAN SECTION: A RETROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Keywords
.............
Abstract
Background: Postoperative pain management following Caesarean section is crucial to facilitate early ambulation, maternal-infant bonding, and breastfeeding. Local wound infiltration with ropivacaine is a simple and cost-effective technique with minimal systemic side effects. This study aimed to evaluate the efficacy of subcutaneous ropivacaine wound infiltration in reducing postoperative pain and analgesic requirements following Caesarean section.
Methods: This retrospective observational study included 200 ASA II parturients undergoing elective Caesarean section under spinal anaesthesia at Sher-i-Kashmir Institute of Medical Sciences. Patients were divided into two groups: Group A (n=100) received 30 ml of 0.75% ropivacaine infiltration at the Pfannenstiel incision site before skin closure, and Group B (n=100) received no infiltration. Postoperative pain was assessed using a Visual Analogue Scale (VAS) at regular intervals for 24 hours. Rescue analgesia (IV paracetamol) requirements, time to first analgesia, and adverse effects were recorded.
Results: Demographic variables were comparable between groups. Group A had significantly lower VAS scores compared to Group B at most time points (p<0.05). The mean time to first rescue analgesia was longer in Group A (3.9±1.02 h) than in Group B (2.3±0.93 h, p<0.001). Total paracetamol consumption was significantly lower in Group A (1880±670.8 mg) compared to Group B (2610±566.6 mg, p<0.001). Adverse effects were minimal and comparable.
Conclusion: Subcutaneous wound infiltration with ropivacaine significantly reduces postoperative pain intensity and analgesic requirements following Caesarean section, prolonging the time to first rescue analgesia without increasing adverse effects. This simple, cost-effective technique enhances postoperative recovery and maternal comfort.
References
2. Patrick NA, et al. Analgesic effects of wound infiltration with 300 mg ropivacaine. Br J Anaesth. 1998;81(6):981–983.
3. Ester F, et al. Continuous wound infusion of 0.5% ropivacaine for postoperative pain management. Br J Anaesth. 2008;101(6):841–847.
4. Kehlet H, et al. Multimodal strategies to improve surgical outcome. Am J Surg. 2002;183(6):630–641.
5. Woolf CJ, et al. Mechanisms of central sensitization and pain hypersensitivity. Pain. 2007;131 Suppl 1:S2–S11.
6. Bamigboye AA, et al. Caesarean section wound infiltration with local anesthesia for postoperative pain relief. Cochrane Database Syst Rev. 2010;(7):CD006954.
7. Dahl JB, et al. Pathophysiology and management of postoperative pain. Br J Anaesth. 1999;83(2):189–195.
8. Tam KW, et al. Effect of wound infiltration with ropivacaine or bupivacaine analgesia in breast cancer surgery. Breast J. 2015;21(6):650–658.
9. Katz J, et al. Acute pain after surgery and its consequences. Curr Opin Anaesthesiol. 2009;22(5):796–801.
10. Gautam A, et al. Local infiltration of ropivacaine hydrochloride for postoperative analgesia in caesarean section. J Clin Diagn Res. 2018;12(6):UC05–UC09.
11. Fahima N, et al. Local wound infiltration with ropivacaine for postoperative pain control in Caesarean section. J Obstet Anaesth Crit Care. 2019;9(1):24–29.
12. Thomas D, et al. Continuous wound infiltration of bupivacaine for caesarean analgesia. J Anaesth Clin Pharmacol. 2019;35(3):365–370.
13. Kunpeng L, et al. Efficacy of local infiltration analgesia with ropivacaine for postoperative pain management in cervical laminoplasty. J Orthop Surg Res. 2020;15(1):187.
14. Kunpeng L, et al. Wound infiltration with ropivacaine as an adjuvant to patient controlled analgesia. Spine J. 2020;20(7):1045–1053.
15. Kehlet H, et al. Prevention of chronic pain after surgery: new insights. Lancet. 2006;367(9522):1618–1625.
16. Dahl JB, et al. Role of local anaesthetics in multimodal analgesia. Br J Anaesth. 2011;107(1):i27–i35.
17. Foster RH, et al. Ropivacaine: a review of its pharmacology and therapeutic use. Drugs. 1997;54(4):639–661.
18. McClure JH. Ropivacaine. Br J Anaesth. 1996;76(2):300–307.
19. Kuthiala G, et al. Ropivacaine: A review of its pharmacology and clinical use. Indian J Anaesth. 2011;55(2):104–110.
20. Knudsen K, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine. Br J Anaesth. 1997;78(5):507–514.
21. Xiangnan L, et al. Local anesthetic wound infiltration used for Caesarean section pain relief: a meta-analysis. Int J Obstet Anesth. 2015;24(2):129–136.
22. Jensen MP, et al. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986;27(1):117–126.
23. Kehlet H, et al. Surgical stress response and clinical outcome. Br J Anaesth. 2006;97(6):710–717.
24. Gupta A, et al. Local anaesthetic wound infiltration in multimodal analgesia. Acta Anaesthesiol Scand. 2011;55(7):775–780.
25. Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016;33(3):160–171.

